Carna Biosciences Inc
TSE:4572
Carna Biosciences Inc
Total Liabilities
Carna Biosciences Inc
Total Liabilities Peer Comparison
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Carna Biosciences Inc
TSE:4572
|
Total Liabilities
¥472.4m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
5%
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Total Liabilities
¥32.4B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
3%
|
|
S
|
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
|
Total Liabilities
¥42.2B
|
CAGR 3-Years
26%
|
CAGR 5-Years
10%
|
CAGR 10-Years
4%
|
Medinet Co Ltd
TSE:2370
|
Total Liabilities
¥533m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-9%
|
|
CellSource Co Ltd
TSE:4880
|
Total Liabilities
¥677.7m
|
CAGR 3-Years
30%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
Linical Co Ltd
TSE:2183
|
Total Liabilities
¥9.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
26%
|
See Also
What is Carna Biosciences Inc's Total Liabilities?
Total Liabilities
472.4m
JPY
Based on the financial report for Dec 31, 2023, Carna Biosciences Inc's Total Liabilities amounts to 472.4m JPY.
What is Carna Biosciences Inc's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
5%
Over the last year, the Total Liabilities growth was -24%. The average annual Total Liabilities growth rates for Carna Biosciences Inc have been -22% over the past three years , -12% over the past five years , and 5% over the past ten years .